PARP1 and neoplasm: Ionizing radiation can cause BRCA1 to be exported to the cytoplasm from the nucleus, increasing the sensitivity of PARP inhibitors in the wild-type BRCA1 and homologous recombination proficient tumor cells (Jiang et al., 2011; Yang et al., 2012).